An internist evaluates a 66-year-old female patient who recently relocated to the area and wants to establish primary care. She has an intact uterus and cervix. She provides comprehensive medical records from her previous provider. Review of these records shows negative cervical cytology and human papillomavirus (HPV) co-testing at ages 55, 60, and 64. She has never had an abnormal Papanicolaou test or a history of cervical dysplasia. She is currently sexually active with her husband of 40 years. Which of the following is the most appropriate next step regarding cervical cancer screening for this patient?
- Discontinue cervical cancer screeningAnswer
- BPerform cervical cytology alone today
- CPerform cervical cytology and HPV co-testing today
- DSchedule cervical cytology and HPV co-testing at age 69
- EPerform primary high-risk HPV testing alone today
Answer
Discontinue cervical cancer screening.
The correct action is to discontinue cervical cancer screening. According to the United States Preventive Services Task Force (USPSTF), routine screening for cervical cancer should be discontinued in women older than 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer (e.g., history of high-grade precancerous lesions, in utero diethylstilbestrol exposure, or immunocompromise). Adequate prior screening is defined as three consecutive negative cytology results, or two consecutive negative HPV or co-testing results within 10 years prior to cessation of screening, with the most recent test occurring within 5 years. This patient meets these criteria, as she had two negative co-tests at ages 60 and 64.
Step-by-Step Solution
Key Concept
Cervical cancer screening cessation guidelines